OR WAIT null SECS
Michael D. Clayman, MD, is chief executive officer and co-founder, Flexion Therapeutics.
Video
Treatment of the osteoarthritis has been at a standstill, with short-term pain management with steroid injections considered standard care. However, a promising new therapeutic approach may help to sustain pain relief over time.